• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan.甲硝唑在日本基于沃克（伏诺拉生）的幽门螺杆菌治疗中的重要性。
Intern Med. 2023 Aug 15;62(16):2299-2300. doi: 10.2169/internalmedicine.1282-22. Epub 2023 Jan 12.
2
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.基于 vonoprazan 的三联疗法与基于药敏的质子泵抑制剂三联疗法根除幽门螺杆菌的非劣效性研究。
Ann Clin Microbiol Antimicrob. 2018 Jun 28;17(1):29. doi: 10.1186/s12941-018-0281-x.
3
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.基于克拉霉素耐药性，对于青霉素过敏的患者，采用沃诺拉赞、克拉霉素和甲硝唑三联疗法进行幽门螺杆菌根除治疗。
Intern Med. 2023 Aug 15;62(16):2301-2306. doi: 10.2169/internalmedicine.0789-22. Epub 2023 Jan 12.
4
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.基于质子泵抑制剂的1周三联疗法治疗失败后幽门螺杆菌对抗生素继发耐药的发生率：一项前瞻性研究
Dig Liver Dis. 2000 Nov;32(8):667-72. doi: 10.1016/s1590-8658(00)80327-8.
5
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.日本根据克拉霉素药敏试验评估幽门螺杆菌根除治疗的结果。
Helicobacter. 2020 Aug;25(4):e12698. doi: 10.1111/hel.12698. Epub 2020 May 5.
6
Efficacy of Vonoprazan for Helicobacter pylori Eradication.沃克帕唑用于根除幽门螺杆菌的疗效。
Intern Med. 2020 Jan 15;59(2):153-161. doi: 10.2169/internalmedicine.2521-18. Epub 2019 Jun 27.
7
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.在各种治疗策略中，联合治疗对幽门螺杆菌的根除率最高。
World J Gastroenterol. 2015 Jan 7;21(1):351-9. doi: 10.3748/wjg.v21.i1.351.
8
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication.基于沃克帕唑的含克拉霉素一线三联疗法的优越性：一项关于幽门螺杆菌根除的前瞻性多中心队列研究。
Intern Med. 2017;56(11):1277-1285. doi: 10.2169/internalmedicine.56.7833. Epub 2017 Jun 1.
9
The best and worst treatments for Helicobacter pylori.幽门螺杆菌的最佳和最差治疗方法。
BMJ. 2015 Aug 19;351:h4146. doi: 10.1136/bmj.h4146.
10
Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.年龄对沃克帕唑三联疗法根除幽门螺杆菌有效性的影响。
Intern Med. 2019 Jun 1;58(11):1549-1555. doi: 10.2169/internalmedicine.2233-18. Epub 2019 Feb 1.

本文引用的文献

1
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.基于克拉霉素耐药性，对于青霉素过敏的患者，采用沃诺拉赞、克拉霉素和甲硝唑三联疗法进行幽门螺杆菌根除治疗。
Intern Med. 2023 Aug 15;62(16):2301-2306. doi: 10.2169/internalmedicine.0789-22. Epub 2023 Jan 12.
2
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.Vonoprazan 三联和双联疗法治疗美国和欧洲的幽门螺杆菌感染：随机临床试验。
Gastroenterology. 2022 Sep;163(3):608-619. doi: 10.1053/j.gastro.2022.05.055. Epub 2022 Jun 6.
3
High Body Mass Index Is Correlated with the Success of Vonoprazan-Based Second-Line Therapy for Helicobacter Pylori Infection.高身体质量指数与基于 vonoprazan 的二线治疗幽门螺杆菌感染的成功率相关。
Tohoku J Exp Med. 2021 Feb;253(2):85-94. doi: 10.1620/tjem.253.85.
4
Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naïve cohort of junior high school students in Japan.日本初高中生幽门螺杆菌感染患者采用沃诺拉赞为基础的双联疗法联合阿莫西林治疗的临床影响。
J Gastroenterol. 2020 Oct;55(10):969-976. doi: 10.1007/s00535-020-01709-4. Epub 2020 Jul 14.
5
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.日本根据克拉霉素药敏试验评估幽门螺杆菌根除治疗的结果。
Helicobacter. 2020 Aug;25(4):e12698. doi: 10.1111/hel.12698. Epub 2020 May 5.
6
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line treatment: a multicentre randomised trial in Japan.七日 vonoprazan 与低剂量阿莫西林双联疗法作为一线治疗：日本多中心随机试验。
Gut. 2020 Jun;69(6):1019-1026. doi: 10.1136/gutjnl-2019-319954. Epub 2020 Jan 8.
7
Efficacy of Vonoprazan for Helicobacter pylori Eradication.沃克帕唑用于根除幽门螺杆菌的疗效。
Intern Med. 2020 Jan 15;59(2):153-161. doi: 10.2169/internalmedicine.2521-18. Epub 2019 Jun 27.
8
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南：2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
9
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.幽门螺杆菌抗生素耐药性的流行情况：世界卫生组织区域的系统评价和荟萃分析。
Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7.
10
First-Line Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin.对青霉素过敏患者使用沃克帕唑、克拉霉素和甲硝唑进行一线根除治疗
Gastroenterol Res Pract. 2017;2017:2019802. doi: 10.1155/2017/2019802. Epub 2017 Oct 18.

Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan.

作者信息

Suzuki Sho, Ishibashi Fumiaki, Gotoda Takuji

机构信息

Department of Gastroenterology, International University of Health and Welfare Ichikawa Hospital, Japan.

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.

出版信息

Intern Med. 2023 Aug 15;62(16):2299-2300. doi: 10.2169/internalmedicine.1282-22. Epub 2023 Jan 12.

DOI:10.2169/internalmedicine.1282-22
PMID:36631099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10484766/
Abstract
摘要